Skip to content

3M™ Tegaderm™ 1683Recalls & reported problems

3M Deutschland GmbH · 3M™ Tegaderm™ I.V. Advanced Securement Dressing, 1683, 2-1/2 in x 2-3/4 in, 6.5 cm x 7 cm, 100/ct 4ct/Case · Class 1

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00707387808150), received between Nov 14, 2025 and Nov 14, 2025 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 1 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Skin Inflammation/ Irritation1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 14, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE PATIENT RECEIVED INTRAVENOUS FLUID THERAPY VIA AN INDWELLING INTRAVENOUS NEEDLE, SECURED WITH A 3M¿ TEGADERM¿ I.V. ADVANCED SECUREMENT DRESSING. APPROXIMATELY ONE HOUR AFTER APPLICATION, THE PATIENT DEVELOPED SKIN FLUSHING SPREADING FROM THE LEFT HAND TO THE ENTIRE LEFT UPPER LIMB, ACCOMPANIED BY SCATTERED MILLET-LIKE PAPULES AND ITCHY SKIN. THE TRANSPARENT DRESSING WAS IMMEDIATELY REPLACED WITH ADHESIVE TAPE FOR FIXATION. THE ATTENDING PHYSICIAN WAS NOTIFIED AND A 0.9% SODIUM CHLORIDE INJECTION AND 10MG DEXAMETHASONE SODIUM PHOSPHATE INJECTION WERE ADMINISTERED INTRAVENOUSLY. APPROXIMATELY 30 MINUTES AFTER MEDICATION, THE PATIENT¿S ITCHING GRADUALLY SUBSIDED, AND THE RASH RESOLVED WITHIN ABOUT 2 HOURS. NO RECURRENCE OF SYMPTOMS WAS OBSERVED AFTER THE ADHESIVE TAPE WAS USED FOR FIXATION.

    Patient problems: Skin Inflammation/ Irritation

    MAUDE report 23558542 ↗

Other DEVICE, INTRAVASCULAR CATHETER SECUREMENT devices

All DEVICE, INTRAVASCULAR CATHETER SECUREMENT devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.